Home » SPIRE RECEIVES PREMIER CONTRACT FOR CHRONIC DIALYSIS CATHETERS
SPIRE RECEIVES PREMIER CONTRACT FOR CHRONIC DIALYSIS CATHETERS
Spire has announced that Spire Biomedical, its wholly owned subsidiary, has been awarded a three-year contract to offer its dialysis catheter products to Premier hospitals. This Group Purchasing Organization (GPO) agreement, effective March 1, allows Spire to offer its line of high-performance catheters to nearly 200 Premier hospital and healthcare systems comprised of more than 1,500 hospital facilities in the U.S.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct